Funds holding LIMINATUS PHARMA INC
ISIN US53271X1081 · United States
- Fund holders
- 5
- Of which ETFs
- 0 5 other funds
- Value held
- 23.3K $
- Share of capital
- 0.2 % of 67.2M shares on Aug 14, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 77,300 | 12.7K $ | 0.12 % | as of May 31, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 50,440 | 5.6K $ | 0.08 % | as of Jun 30, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 16,770 | 2.8K $ | 0.02 % | as of May 31, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 8,096 | 1.3K $ | 0.01 % | as of May 31, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 6,202 | 1K $ | 0.01 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 5 | 0 | 158,808 | +46.0 % |
| 2026Q2 | 5 | 0 | 108,762 | +3.8 % |
| 2026Q1 | 5 | 0 | 104,759 | -0.2 % |
| 2025Q4 | 5 | +4 | 104,994 | +43.0 % |
| 2025Q3 | 1 | 73,424 |
Institutional managers
13 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| CITADEL ADVISORS LLC | 677,518 | 116.5K $ | as of Mar 31, 2026 |
| Cygnus Capital Advisors, LLC | 350,000 | 60 $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 117,783 | 20.2K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 71,318 | 12.3K $ | as of Mar 31, 2026 |
| UBS Group AG | 54,578 | 9.4K $ | as of Mar 31, 2026 |
| Vanguard Personalized Indexing Management, LLC | 34,706 | 6K $ | as of Mar 31, 2026 |
| Virtu Financial LLC | 27,468 | 5 $ | as of Mar 31, 2026 |
| TWO SIGMA SECURITIES, LLC | 22,039 | 3.8K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 19,000 | 3.3K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 13,254 | 2.3K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 7,567 | 1.3K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 6,769 | 1.2K $ | as of Mar 31, 2026 |
| Farther Finance Advisors, LLC | 14 | 2 $ | as of Mar 31, 2026 |
Declared shareholders of LIMINATUS PHARMA INC
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Valetudo Therapeutics LLC and 1 other | 14.30 % | 9,617,954 | as of Jul 2, 2026 · SCHEDULE 13D |
| Ewon Comfortech Co., Ltd. | 10.90 % | 5,500,000 | as of Jun 24, 2026 · SCHEDULE 13G |
| Samda Biolab Co., Ltd. | 5.10 % | 3,426,548 | as of Jul 2, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding LIMINATUS PHARMA INC". https://titelia.com/en/stocks/liminatus-pharma-inc-US53271X1081